Here are five new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists:
Pharmacy
Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1 medication approved to treat metabolic associated steatohepatitis, a serious condition marked by liver scarring. The FDA granted the approval Aug. 15. Injectable GLP-1 drugs primarily treat obesity…
The statistics are clear: GLP-1 medications can have a dramatic effect on cardiovascular health. Recent research has shown both semaglutide and tirzepatide — the active ingredients in Ozempic and Wegovy, and Mounjaro and Zepbound, respectively — can significantly reduce the…
A commonly available nasal spray may significantly reduce the risk of COVID-19 infections, according to clinical trial results. Researchers from Saarland University Hospital in Germany led the study, the results of which were published Sept. 2 in JAMA Internal Medicine.…
Eli Lilly has partnered with Chinese digital healthcare platform JD Health International to sell its GLP-1s to patients online, Bloomberg reported Aug. 29. The collaboration will offer a streamlined, one-stop service through JD Health, including online consultations, prescriptions, drug delivery…
Advertisement
Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature Medicine. Researchers from Philadelphia-based University of Pennsylvania’s Abramson Cancer Center…
A federal rule enabling real-time access to prescription drug pricing, coverage details and prior authorization requirements is set to take effect Oct. 1. The regulation, finalized in July as part of the CMS Inpatient Prospective Payment System and Long-Term Care…
Cigna subsidiary Evernorth Health Services is investing $3.5 billion in Shields Health Solutions, a specialty pharmacy company launched after Walgreens went private. Shields partners with more than 80 health systems across more than 1,000 hospitals and clinics nationwide to help…
The FDA has approved Biogen’s Alzheimer’s drug Leqembi for injection to treat individuals with mild cognitive impairment or mild dementia. The drug can now be administered as a once-weekly injection using an autoinjector device, compared to the previous method of…
President Donald Trump demanded that pharmaceutical companies release data for “success rates” of their COVID-19 medications to clear up what he called a “discrepancy mess.” In a Sept. 1 Truth Social post, President Trump said he had been shown “extraordinary”…